and there could always be a new partner for OPMD - there must have been many suitors when they were shopping it around before the Axovant deal. A few of them may resume discussions. That would restore our value quickly. Add to that new proprietary indications and we are back in the game.
- Forums
- ASX - By Stock
- BLT
- Ann: Update on Oculopharyngeal Muscular Dystrophy Program
Ann: Update on Oculopharyngeal Muscular Dystrophy Program, page-18
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online